COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease.
COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease.
Wien Klin Wochenschr. 2020 Dec 08;:
Authors: Eder M, Strassl R, Kläger J, Aigner C, Thalhammer F, Kikić Ž
Abstract
In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.
PMID: 33289854 [PubMed - as supplied by publisher]
Source: Wiener Klinische Wochenschrift - Category: General Medicine Authors: Eder M, Strassl R, Kläger J, Aigner C, Thalhammer F, Kikić Ž Tags: Wien Klin Wochenschr Source Type: research